Management of Viral Hepatitis C: Therapeutic and Economic Study in Morocco

Abderrahim Foullous, Ali Asdadi, Hifdi Abderafiaa, Warda Baha, Fatiha Lazar, Abderrahman Hammoumi, Abdelouaheb Benani


Viral hepatitis C is not only a major public health problem by its significant morbidity and mortality worldwide, but also a medical and economical burden. Over the last 5 years, numerous research laboratories have enabled the development of several direct acting anti-HCV molecules whose effectiveness is well established. Great progress has been made in particular in the field of therapy although the cost of these treatments is today the focus of discussions, dissemination of new antiviral treatments to direct action should be a priority for public powers to heal and reduce the complications of this disease, thus the line ministry has given permission to market a generic of sofosbuvir drugs at an affordable price, acceptable and 80 times cheaper than the princeps. The first part of this paper elucidates the news of new drugs available to treat HCV, in the second part economical study aspects of the different therapeutical strategies currently available in Morocco. Thus we will study impacts of economical consequences of the therapy used against chronic hepatitis C.

Keywords: Sofosbuvir; hepatitis C; direct-acting antiviral; guideline and management of viral hepatitis C; therapeutic and economic study in morocco; sustained virological response

Full Text: PDF
Download the IISTE publication guideline!

To list your conference here. Please contact the administrator of this platform.

Paper submission email:

ISSN (Paper)2224-3208 ISSN (Online)2225-093X

Please add our address "" into your email contact list.

This journal follows ISO 9001 management standard and licensed under a Creative Commons Attribution 3.0 License.

Copyright ©